• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部不可切除肝细胞癌的管理

Managing localized unresectable hepatocellular carcinoma.

作者信息

Narang-Master Jyoti, Rizzolo Denise

机构信息

Jyoti Narang-Master is chief PA for the Department of Surgery at Bellevue Hospital, affiliated with NYU Langone. Denise Rizzolo is an associate professor in the PA program at Seton Hall University in South Orange, N.J., an assistant clinical professor in the Pace completion program in New York City, and practices urgent care in Springfield, N.J. The authors have disclosed no potential conflicts of interest, financial or otherwise.

出版信息

JAAPA. 2015 Jan;28(1):27-34. doi: 10.1097/01.JAA.0000458854.46279.d8.

DOI:10.1097/01.JAA.0000458854.46279.d8
PMID:25486501
Abstract

Hepatocellular carcinoma is becoming more common, and numerous treatment algorithms are available for this complex disease. This article reviews screening, diagnosis, staging, and management of hepatocellular carcinoma, including various treatments for patients who are not candidates for surgical resection and transplantation.

摘要

肝细胞癌正变得越来越常见,针对这种复杂疾病有众多治疗方案。本文综述了肝细胞癌的筛查、诊断、分期及管理,包括针对不适合手术切除和移植的患者的各种治疗方法。

相似文献

1
Managing localized unresectable hepatocellular carcinoma.局部不可切除肝细胞癌的管理
JAAPA. 2015 Jan;28(1):27-34. doi: 10.1097/01.JAA.0000458854.46279.d8.
2
Hepatocellular carcinoma: options for diagnosing and managing a deadly disease.肝细胞癌:诊断和治疗致命疾病的选择。
Cleve Clin J Med. 2013 Oct;80(10):645-53. doi: 10.3949/ccjm.80a.12163.
3
Clinical value of continuous administration of sorafenib in combination with modified transarterial chemoembolization in patients with unresectable hepatocellular carcinoma.索拉非尼持续给药联合改良经动脉化疗栓塞术治疗不可切除肝细胞癌患者的临床价值
Chin Med J (Engl). 2013 Jan;126(2):385-6.
4
Sorafenib in combination with transarterial chemoembolization for the treatment of hepatocellular carcinoma.索拉非尼联合经动脉化疗栓塞术治疗肝细胞癌。
Clin Adv Hematol Oncol. 2016 Aug;14(8):585-7.
5
Transarterial chemoembolization and sorafenib in patients with intermediate-stage hepatocellular carcinoma: time to enter routine clinical practice?经动脉化疗栓塞术与索拉非尼治疗中期肝细胞癌患者:是时候进入常规临床实践了吗?
Future Oncol. 2015;11(17):2371-3. doi: 10.2217/FON.15.173. Epub 2015 Aug 13.
6
Liver tumors and loco-regional therapy.肝脏肿瘤与局部区域治疗。
Wien Med Wochenschr. 2013 Mar;163(5-6):107-8. doi: 10.1007/s10354-013-0188-2.
7
Right sided heart mass reveals hepatocellular carcinoma.右侧心脏肿物提示肝细胞癌。
Heart Lung Circ. 2012 Dec;21(12):817-8. doi: 10.1016/j.hlc.2012.06.022. Epub 2012 Jul 26.
8
Hepatocellular carcinoma: current questions and future directions.肝细胞癌:当前问题与未来方向
Clin Adv Hematol Oncol. 2015 Mar;13(3):176-9.
9
Effects of sorafenib combined with chemoembolization and radiofrequency ablation for large, unresectable hepatocellular carcinomas.索拉非尼联合化疗栓塞和射频消融治疗大的不可切除肝细胞癌的疗效。
Chin Med J (Engl). 2013 Nov;126(22):4270-6.
10
Treatment of intermediate-stage hepatocellular carcinoma.中期肝细胞癌的治疗
Clin Adv Hematol Oncol. 2015 Aug;13(8):501-3.

引用本文的文献

1
A review of the literature on the use of CRISPR/Cas9 gene therapy to treat hepatocellular carcinoma.CRISPR/Cas9 基因治疗治疗肝细胞癌的文献综述。
Oncol Res. 2024 Feb 6;32(3):439-461. doi: 10.32604/or.2023.044473. eCollection 2024.